Development of Orodispersible Tablets of Candesartan Cilexetil-β-cyclodextrin Complex

Figure 1

FTIR spectra. (a) FTIR spectra of candesartan cilexetil, (b) FTIR spectra of β-cyclodextrin, (c) FTIR spectrum of Candesartan cilexetil-β-cyclodextrin complex prepared by kneading technique (1 : 5 molar ratio of drug : βCD), (d) FTIR spectrum of Candesartan cilexetil-β-cyclodextrin complex prepared by lyophilisation technique (1 : 5 molar ratio of drug : βCD), (e) FTIR spectrum of Candesartan cilexetil-β-cyclodextrin freeze-dried complex with croscarmellose sodium, (f) FTIR spectrum of Candesartan cilexetil-β-cyclodextrin freeze-dried complex with crospovidone, (g) FTIR spectrum of Candesartan cilexetil-β-cyclodextrin freeze-dried complex with low substituted hydroxy propyl cellulose, and (h) FTIR spectrum of Candesartan cilexetil-β-cyclodextrin freeze-dried complex with sodium starch glycolate.